Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Defined term · Evidence assessment

Network meta-analysis

A synthesis combining direct and indirect comparisons across a connected set of interventions. The Institute publishes network estimates with its transitivity assessment attached and does not publish…

Document identifier
CEI-GT-025
Series
Defined term
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Network meta-analysis

§1.1Also known as

Mixed treatment comparison

§1.2Category

Evidence assessment — Terms describing how the Institute judges and reports the strength of evidence.

§1.3Related terms

  • Transitivity — The assumption, required for indirect comparison, that participants in the contributing trials could in principle have been randomised to any of the compared…
  • Indirect comparison — An estimate of the difference between two interventions that have not been compared directly, derived through their comparisons with a common comparator. Weaker than a…
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.